News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Date Title Source
Apr-26-22 08:15AM Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th ACCESSWIRE
Nov-16-21 09:58AM Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update GlobeNewswire
Aug-30-21 09:15AM Protagenic Therapeutics to Host Virtual Science Review Wednesday, September 8th at 10 AM ET GlobeNewswire
Aug-17-21 07:45AM Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update GlobeNewswire
Jul-23-21 04:21PM Protagenic Therapeutics Updates Timeline for Commencement of Patient Enrollment for PT00114 Clinical Trial GlobeNewswire
Jul-08-21 11:20AM 50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 ACCESSWIRE
Jul-06-21 06:17AM Protagenic Therapeutics to Host Webinar with Dr. Maurizio Fava for its Lead Molecule PT00114 on Tuesday, July 13th at 10:00 AM ET GlobeNewswire
Jun-23-21 09:35AM 50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 ACCESSWIRE
Jun-16-21 09:15AM Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th GlobeNewswire
Apr-29-21 03:06PM Protagenic Therapeutics, Inc. Announces Closing of $13.2 Million Public Offering and Uplisting to Nasdaq GlobeNewswire
Apr-26-21 08:58PM Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering GlobeNewswire
Dec-16-20 09:15AM Dr. Maurizio Fava of Massachusetts General Hospital to Serve as Principal Investigator for PT00114 Clinical Trial GlobeNewswire
Sep-08-20 12:10PM Protagenic Therapeutics Completes $2.0 Million Convertible Note Financing GlobeNewswire